Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthokine versus radiofrequency ablation for idiopathic trigeminal neuralgia
IRCT20190618043923N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2022
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous conditioned serum in Idiopathic Trigeminal Neuralgia (TN) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Pain intensity. Started Mar 2022; status: completed.
02
Drugs
autologous conditioned serum
03
Conditions
Idiopathic Trigeminal Neuralgia (TN)
Beyond the preview
Go deeper on IRCT20190618043923N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043923N6.